• awesomeicons6/solid/lock 100% Secure Online Payments

ABBV-744

Selleck

ABBV-744 (S8723-GRP)

View Data Sheet

Products

Sort by arrow-down-short-wide arrow-up-short-wide
Cat #
Size
Price
Cat # Size
chevron-left chevron-right
of

Description

ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2, BRD3 and BRD4. It is developed for treating AML and cancers.

Specifications

Manufacturer Cat# S8723
Target Epigenetic Reader Domain